Sage Mountain Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71M | Buy |
14,615
+563
| +4% | +$105K | 0.18% | 68 |
|
|
2025
Q1 | $2.94M | Buy |
14,052
+214
| +2% | +$44.8K | 0.22% | 59 |
|
|
2024
Q4 | $2.46M | Buy |
13,838
+2,074
| +18% | +$369K | 0.18% | 65 |
|
|
2024
Q3 | $2.32M | Buy |
11,764
+1,177
| +11% | +$232K | 0.2% | 60 |
|
|
2024
Q2 | $1.82M | Buy |
10,587
+1,101
| +12% | +$189K | 0.17% | 64 |
|
|
2024
Q1 | $1.73M | Buy |
9,486
+653
| +7% | +$119K | 0.18% | 64 |
|
|
2023
Q4 | $1.37M | Buy |
8,833
+734
| +9% | +$114K | 0.16% | 67 |
|
|
2023
Q3 | $1.21M | Sell |
8,099
-108
| -1% | -$16.1K | 0.17% | 65 |
|
|
2023
Q2 | $1.11M | Buy |
8,207
+225
| +3% | +$30.3K | 0.16% | 67 |
|
|
2023
Q1 | $1.27M | Buy |
7,982
+2,519
| +46% | +$401K | 0.21% | 57 |
|
|
2022
Q4 | $883K | Buy |
5,463
+230
| +4% | +$37.2K | 0.2% | 44 |
|
|
2022
Q3 | $702K | Sell |
5,233
-287
| -5% | -$38.5K | 0.19% | 45 |
|
|
2022
Q2 | $845K | Sell |
5,520
-312
| -5% | -$47.8K | 0.15% | 117 |
|
|
2022
Q1 | $945K | Buy |
5,832
+97
| +2% | +$15.7K | 0.15% | 120 |
|
|
2021
Q4 | $776K | Sell |
5,735
-13
| -0.2% | -$1.76K | 0.09% | 202 |
|
|
2021
Q3 | $620K | Buy |
5,748
+985
| +21% | +$106K | 0.09% | 216 |
|
|
2021
Q2 | $536K | Buy |
4,763
+2,051
| +76% | +$231K | 0.09% | 217 |
|
|
2021
Q1 | $294K | Buy |
+2,712
| New | +$294K | 0.06% | 235 |
|